What Is Ranitidine Used For and Why Was It Recalled?

Ranitidine was a widely used acid-reducing medication sold under the brand name Zantac. It treated stomach ulcers, gastroesophageal reflux disease (GERD), heartburn, and conditions involving excess stomach acid production. However, ranitidine is no longer available. In April 2020, the FDA requested that all prescription and over-the-counter ranitidine products be pulled from the market due to contamination concerns. If you’re searching for what ranitidine was used for, you’re likely looking for context on a medication you once took or trying to find a suitable replacement.

How Ranitidine Worked

Ranitidine belonged to a class of drugs called H2 receptor antagonists, or H2 blockers. After you eat, your body releases a chemical called histamine that binds to specific receptors on the cells lining your stomach. That binding triggers those cells to produce stomach acid. Ranitidine worked by attaching to those same receptors first, essentially blocking histamine from doing its job. With less acid being produced, the stomach and esophagus had a chance to heal from damage, and symptoms like heartburn and indigestion eased up.

Conditions Ranitidine Treated

Ranitidine had a broad range of uses, both prescription and over-the-counter. Its primary prescription indications included:

  • Duodenal and stomach ulcers. These are open sores in the lining of the upper digestive tract. Ranitidine reduced acid production long enough for ulcers to heal. In clinical trials, roughly 84% to 96% of duodenal ulcers healed within four weeks of treatment.
  • GERD. When stomach acid repeatedly flows back into the esophagus, it causes chronic heartburn and can damage the tissue. Ranitidine was shown to be more effective than placebo for relieving heartburn and other GERD symptoms in six-week trials.
  • Erosive esophagitis. A more severe form of acid damage where the esophageal lining develops visible erosions. Ranitidine helped reduce the acid exposure that drives this condition.
  • Zollinger-Ellison syndrome. A rare condition where tumors cause the stomach to produce dangerously high amounts of acid. Patients with this syndrome required much higher and more frequent doses, sometimes taken every six to eight hours, with the amount adjusted based on how much acid the stomach was still producing.

Over-the-counter ranitidine, typically sold as 75 mg or 150 mg tablets, was used for everyday heartburn, acid indigestion, and sour stomach. Millions of people took it before or after meals to prevent or relieve occasional symptoms without a prescription.

Ranitidine also had several off-label uses. Doctors sometimes prescribed it to prevent stress ulcers in hospitalized patients, protect the stomach lining from damage caused by anti-inflammatory painkillers like ibuprofen, and reduce the risk of aspirating stomach acid during surgery. In children, ranitidine syrup was commonly prescribed for acid reflux, where stomach contents flow back into the food pipe and cause pain.

Why Ranitidine Was Removed From the Market

On April 1, 2020, the FDA announced it was requesting manufacturers withdraw all ranitidine products from the market immediately, covering both prescription and over-the-counter versions. The reason was contamination with NDMA, a probable human carcinogen. Testing revealed that NDMA levels in ranitidine could increase over time, particularly when stored at higher temperatures, pushing the contamination above acceptable safety limits.

This wasn’t a voluntary recall by one manufacturer. The FDA asked every company making ranitidine to stop selling it. The concern wasn’t that ranitidine didn’t work. It was effective for the conditions it treated. The problem was specifically the NDMA contamination, which appeared to be inherent to the ranitidine molecule itself rather than a manufacturing defect.

What Replaced Ranitidine

If you previously relied on ranitidine, several alternatives cover the same conditions. They fall into two main categories.

Other H2 Blockers

Famotidine is the most direct replacement. It works through the same mechanism as ranitidine, blocking histamine from triggering acid production, and it’s available both over the counter and by prescription. The FDA did not find the same NDMA contamination issues with famotidine. Cimetidine is another H2 blocker still on the market, though it’s used less frequently due to a higher potential for drug interactions.

Proton Pump Inhibitors

For more severe acid-related conditions like GERD with esophageal damage or stubborn ulcers, proton pump inhibitors (PPIs) are often the go-to option. These include omeprazole (Prilosec), esomeprazole (Nexium), lansoprazole, and pantoprazole (Protonix). PPIs block acid production at a different point in the process and are generally more potent than H2 blockers. Some are available over the counter for short-term use, while others require a prescription. In head-to-head ulcer trials, omeprazole healed about 91% of duodenal ulcers at four weeks compared to 80% with ranitidine, illustrating the stronger acid suppression PPIs provide.

For occasional heartburn that ranitidine once handled, over-the-counter famotidine or a short course of an OTC proton pump inhibitor will cover the same ground. For chronic conditions, your prescriber can match the right alternative to your specific situation.